Humanigen Forum: Community User: Rothschild123

Tja.. es bleibt ein zock... hab nachgelegt

Zock ja

Glaub au eher des wird nix

Tja ich schon... halte hier langfristig

“We believe data from our LIVE-AIR study provides a compelling argument for utilizing CRP as a biomarker to identify hospitalized patients for whom lenzilumab may provide the greatest benefit and we look forward to results of the NIH’s ACTIV-5/BET-B study of lenzilumab, which is designed to confirm this approach,” stated Dr. Cameron Durrant, Chairman and CEO, Humanigen. “Following consultation with the FDA, Humanigen expects that if the ACTIV-5/BET-B study is positive, which has its primary analysis focused on patients with CRP

Schau dir den Nasdac an.... die letzte Zeit... davon sind wir hier auch abhängig

Warum fällt das Ding ständig..mann

Hoffen wir die Ergebnisse sind gut bzw signifikant positiv

Spannend!!

Lenzilumab in COVID-19 On June 30, 2022, the Company issued a press release confirming that the Company had received notice from the National Institute of Allergy and Infectious Diseases (“NIAID”) that it has completed database lock for its Big Effect Trial of lenzilumab (“BET-B”) being conducted in collaboration with the National Institutes of Health (“NIH”) public-private partnership Accelerating COVID-19 Therapeutic Innovations and Vaccines-5 (“ACTIV-5”). The Company expects to receive topline results from NIH/NIAID in July.

Sollten die TLD nicht gut/ausreichend sein wie seht ihr dann die weitere Entwicklung der Company langfristig?

Ahh sorry und Danke Dir

TLD= Top-Line Data

Was ist TLD?

Die gibts... aber die firma ist halt wenig bekannt für den Normalbürger. Bin zuversichtlich ab Herbst